CN1166367C - Medicine for external application for curing psoriasis - Google Patents
Medicine for external application for curing psoriasis Download PDFInfo
- Publication number
- CN1166367C CN1166367C CNB011282800A CN01128280A CN1166367C CN 1166367 C CN1166367 C CN 1166367C CN B011282800 A CNB011282800 A CN B011282800A CN 01128280 A CN01128280 A CN 01128280A CN 1166367 C CN1166367 C CN 1166367C
- Authority
- CN
- China
- Prior art keywords
- medicine
- psoriasis
- external application
- paste
- calomelas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to externally applied medicine for treating psoriasis, which comprises the components by weight: 3 to 10 g of white downborne elixir, 5 to 15 g of calomelas and 3 to 10 portions of hydrargyri oxydum rubrum, and the components are prepared into fine powder to be regulated into externally applied paste with vaseline oil. The paste has the advantages of simple preparation method and low cost and has special effect on psoriasis. By three-year trial, the total effective rate can reach over 95%, and the medicine has certain curative effect on dermatosis such as eczema, flat warts, etc.
Description
Technical field: the present invention relates to a kind of medicine, the psoriasic medicine for external use of promptly a kind of treatment.
Background technology: psoriasis, modern medicine claim " psoriasis ", and when just sending out, the erythema pimple appears in patient skin, and rapid then expanded scope forms coin or map shape, covers squama, the visible thin film of scaling, and visible blood point under the thin film claims psoriasis vulgaris.If skin has pustule, and regular outbreak, psoriasis pustulosa be called.Soak into if skin is diffuse erythema, then be called erythrodermic psoriasis with a large amount of desquamations.At present, a lot of about the antipsoriatic method of rash, but how undesirable curative effect is, what have also needs higher expense and condition.Thereby in pastoral area, vast rural area, this disease is still tormenting many patients.
Summary of the invention: the present invention is directed to the problems referred to above, adopt Chinese herbal medicine to develop topical agent, its weight portion prescription is: Hydrargyrum chloratum Compositum 3-10 part, and Calomelas 5-15 part, Hydrargyri Oxydum Rubrum 3-10 part, Realgar 5-10 part is all got fine powder vaseline oil furnishing external application paste.This ointment method for making is simple, with low cost, and psoriasis is had specially good effect, and through nearly 3 years trying out, total effective rate can reach more than 95%.Dermatosiss such as eczema, verruca plana also there is certain curative effect.
Embodiment: Hydrargyrum chloratum Compositum, Calomelas, Hydrargyri Oxydum Rubrum, the Realgar of weight such as get, porphyrize mixes, with vaseline oil furnishing paste.
Usage: affected part coating skim, twice on the one.
Note not inlet eye, avoid and drink, avoid the pungent stimulating food of ichthyophagy.Warm calm place is suitable in medicine-feeding.If medicine-feeding place pain, in addition red and swollen, should reduce dose.Hydrargyrum allergy sufferers forbidding.
Pharmacodynamic analysis: Hydrargyrum chloratum Compositum belongs to the mixed crystallization of mercuric chloride and calomel, and severe toxicity and intensive corrosivity are arranged, and the effect of eliminating pus and toxicity is also arranged.Calomelas is the mercury compound that hydrargyrum, Alumen, Sal etc. are made with sublimed method, has the skin ulcer of holding back parasite killing, the effect of the relieving constipation of relieving oedema or abdominal distension through diuresis or purgation.Hydrargyri Oxydum Rubrum is the mercuride that hydrargyrum, Alumen, Borax are made into, and is close with the Calomelas drug effect, and the stronger osmosis of adhering to is arranged.Realgar is arsenical crystallization Ore, and often the form with red arsenic sulfide exists.Hydrargyrum chloratum Compositum toxicity is stronger, and is unsuitable oral.Though several toxicity in back are strong, relax, traditional Chinese medical science low dose commonly used is gone into ball and is loose for oral administration.Above-mentioned medicine is mixed, and strong toxicity is slow to differ, and the efficacy of a drug is lasting, and permeability is strong, than single use curative effect multiplication.
Modern medicine is a lot of to psoriatic cause of disease saying, mainly contains " heredity ", " virus ", " bacterial infection ", " Nervous and Mental Factors ", " endocrine factors ", " wound initiation ", " dysbolismus ", " immunocompromised " etc.This medicine is primarily aimed at the causes of disease such as biological virus and antibacterial.Because medicament is the arsenic mercurial, toxicity is stronger, and virus, antibacterial are had kill activity, skilfully use the corrosiveness of medicine in addition, obtain permeability preferably, take into account the violence and the persistency of drug effect, can't survival environment thereby made viral pathogenic bacteria, receive the effect for the treatment of the poisonous disease with poisonous drugs.
The clinical experiment situation:
1, diagnoses and treatment standard: the diagnosis and the treatment standard that adopt each opinion the 32 chapter of always touching upon in " modern dermatological " (publishing house of Shanghai Medical Univ publishes, Yang Guoliang, Wang Xiasheng chief editor) to be proposed.
2, experimental data: clinical treatment 44 examples, wherein cure 35 examples, account for 79.5%.Recur once in 2 years, through medication skin lesion disappearance person 3 people, 6.8%.Remission, but dissatisfied person 4 people of curative effect account for 9%.Ineffective person 2 people account for 4.5%, total effective rate 95.5%.
Claims (1)
1, the psoriasic medicine for external use of a kind of treatment is characterized in that: prescription by weight, and Hydrargyrum chloratum Compositum 3-10 part, Calomelas 5-15 part, Hydrargyri Oxydum Rubrum 3-10 part, Realgar 5-10 part is all got fine powder with vaseline oil furnishing external application paste.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011282800A CN1166367C (en) | 2001-10-11 | 2001-10-11 | Medicine for external application for curing psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011282800A CN1166367C (en) | 2001-10-11 | 2001-10-11 | Medicine for external application for curing psoriasis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1411817A CN1411817A (en) | 2003-04-23 |
CN1166367C true CN1166367C (en) | 2004-09-15 |
Family
ID=4668154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011282800A Expired - Fee Related CN1166367C (en) | 2001-10-11 | 2001-10-11 | Medicine for external application for curing psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1166367C (en) |
-
2001
- 2001-10-11 CN CNB011282800A patent/CN1166367C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1411817A (en) | 2003-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Merz et al. | Fungating wounds–multidimensional challenge in palliative care | |
CN101757117A (en) | Chinese herb medicine conditioner and preparation method thereof | |
CN1100945A (en) | Broad spectrum detoxicating medicine for curing snakebite | |
CN110680870A (en) | Pain-relieving itching-relieving swelling-diminishing detoxifying liquid and preparation method thereof | |
CN1166367C (en) | Medicine for external application for curing psoriasis | |
RU2320329C1 (en) | Method for complex therapy of average-degree oral phlegmons | |
CN1259098C (en) | Exterior-applied Chinese herbal medicine preparation for traumatic infection and inflammation-relieving acesodyne and its preparation method | |
CN107596355A (en) | A kind of Medical pain easing, the exterior-applied gel subsided a swelling, brought down a fever and preparation method thereof | |
CN1067879C (en) | Preparation of medicament containing rare-earth for dermatomycosis | |
RU2284825C1 (en) | Method for treating abscesses, soft tissue phlegmons | |
WO2006099789A1 (en) | A pharmaceutical preparation | |
CN1093277A (en) | Bee glue ointment for curing chilblain | |
CN103585330B (en) | A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof | |
CN112569297A (en) | External medicine for diabetic foot wound | |
CN1273161C (en) | Ru'an oral liquor | |
CN1903214A (en) | Ointment containing red precipitate | |
CN102266408A (en) | Chinese medicine preparation for intervening in cutaneous prutitus and preparation method thereof | |
CN1989950A (en) | Sterilizing effective antipruritic application agent | |
CN1079237C (en) | Dog bone scald medicine | |
RU2196590C1 (en) | Agent carbon-mercury hydrosulfate complex and method of treatment of infectious inflammatory sicknesses | |
Sircus | Healing With Iodine: Your Missing Link To Better Health | |
RU2172634C2 (en) | Bronchial asthma treatment method | |
CN101912398B (en) | Medicament for treating urinary tract infection | |
CN1189183C (en) | Yunnan Heiyao and its application in treating viral, bacterial and fungal diseases | |
CN101129404A (en) | External use medicine for treating psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |